Corticomotoneuronal function in asymptomatic SOD-1 mutation carriers

Clinical Neurophysiology

Volumn 121, Issue 10, 2010, Pages 1781-1785

  Vucic, Steve ^a,e   Winhammar, Jennica M C ^b,c,e   Rowe, Dominic B ^b,c,d   Kiernan, Matthew C ^e  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d MACQUARIE UNIVERSITY   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Diffusion tensor tractography; Familial ALS; SOD 1 mutation carrier

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; SUPEROXIDE DISMUTASE;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIFFUSION TENSOR IMAGING; FAMILIAL DISEASE; FEMALE; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTONEURON; NERVE CELL EXCITABILITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; ACTION POTENTIAL; BRAIN MAPPING; ELECTROSTIMULATION; GENETICS; MIDDLE AGED; MUTATION; NEUROLOGIC EXAMINATION; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL NERVE; PHYSIOLOGY; PROCEDURES; PYRAMIDAL TRACT; REACTION TIME;

ACTION POTENTIALS; ADULT; AMYOTROPHIC LATERAL SCLEROSIS; BRAIN MAPPING; CEREBRAL CORTEX; DIFFUSION TENSOR IMAGING; ELECTRIC STIMULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MOTOR NEURONS; MUTATION; NEUROLOGIC EXAMINATION; PERIPHERAL NERVES; PYRAMIDAL TRACTS; REACTION TIME; SUPEROXIDE DISMUTASE;

EID: 77956121296     PISSN: 13882457     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinph.2010.02.164     Document Type: Article

References (36)

1. Abe O., Aoki S., Hayashi N., Yamada H., Kunimatsu A., Mori H., et al. Normal aging in the central nervous system: quantitative MR diffusion-tensor analysis. Neurobiol Aging 2002, 23:433-441.
2. Abe O., Yamada H., Masutani Y., Aoki S., Kunimatsu A., Yamasue H., et al. Amyotrophic lateral sclerosis: diffusion tensor tractography and voxel-based analysis. NMR Biomed 2004, 17:411-416.
3. Alexander A.L., Lee J.E., Lazar M., Field A.S. Diffusion tensor imaging of the brain. Neurotherapeutics 2007, 4:316-329.
4. Bensimon G., Lacomblez L., Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994, 330:585-591. ALS/Riluzole Study Group.
5. Boillee S., Vande Velde C., Cleveland D.W. ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 2006, 52:39-59.
6. Bruijn L.I., Miller T.M., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004, 27:723-749.
7. Cedarbaum J.M., Stambler N., Malta E., Fuller C., Hilt D., Thurmond B., et al. The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci 1999, 169:13-21. BDNF ALS Study Group (Phase III).
8. Cros D., Chiappa K.H., Gominak S., Fang J., Santamaria J., King P.J., et al. Cervical magnetic stimulation. Neurology 1990, 40:1751-1756.
9. De Carvalho M., Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve 2000, 23:344-352.
10. Desiato M., Bernardi G., Hagi A.H., Boffa L., Caramia M.D. Transcranial magnetic stimulation of motor pathways directed to muscles supplied by cranial nerves in ALS. Clin Neurophysiol 2002, 113:132-140.
11. Eisen A., Kim S., Pant B. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?. Muscle Nerve 1992, 15:219-224.
12. Eisen A., Pant B., Stewart H. Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 1993, 20:11-16.
13. Ellis C.M., Simmonds A., Jones D., Bland J., Dawson J.M., Horsfield M.A., et al. Diffusion tensor MRI assesses corticospinal tract damage in ALS. Neurology 1999, 53:1051-1058.
14. Graham J.M., Papadakis N., Evans J., Widjaja E., Romanowski C.A., Paley M.N., et al. Diffusion tensor imaging for the assessment of upper motor neuron integrity in ALS. Neurology 2004, 63:2111-2119.
15. Kiernan M. Riluzole: a glimmer of hope in the treatment of motor neurone disease. Early experience confirms that riluzole improves survival and is well tolerated. Med J Aust 2005, 182:319-320.
16. Lacomblez L., Bensimon G., Leigh P.N., Guillet P., Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Lancet 1996, 347:1425-1431. Amyotrophic Lateral Sclerosis/Riluzole Study Group II.
17. Aid to the examination of the peripheral nervous system 1976, Medical Research Council, Her Majesty's Stationary Office, London.
18. Mills K.R., Nithi K.A. Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 1997, 20:1137-1141.
19. Ng M.C., Ho J.T., Ho S.L., Lee R., Li G., Cheng T.S., et al. Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation. J Magn Reson Imaging 2008, 27:8-13.
20. Pfefferbaum A., Adalsteinsson E., Sullivan E.V. Frontal circuitry degradation marks healthy adult aging: evidence from diffusion tensor imaging. Neuroimage 2005, 26:891-899.
21. Prout A.J., Eisen A. The cortical silent period and ALS. Muscle Nerve 1994, 17:217-223.
22. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993, 362:59-62.
23. Sach M., Winkler G., Glauche V., Liepert J., Heimbach B., Koch M.A., et al. Diffusion tensor MRI of early upper motor neuron involvement in amyotrophic lateral sclerosis. Brain 2004, 127:340-350.
24. Sage C.A., Peeters R.R., Gorner A., Robberecht W., Sunaert S. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis. Neuroimage 2007, 34:486-499.
25. Sage C.A., Van Hecke W., Peeters R., Sijbers J., Robberecht W., Parizel P., et al. Quantitative diffusion tensor imaging in amyotrophic lateral sclerosis: revisited. Hum Brain Mapp 2009, 30:3657-3675.
26. Shaw P., Kuncl R. Current concepts in the pathogenesis of ALS. Motor Neuron Disease 2002, 37-73. W.B. Saunders, London. K. WR (Ed.).
27. Shaw P.J. Molecular and cellular pathways of neurodegeneration in motor neurone disease. J Neurol Neurosurg Psychiatry 2005, 76:1046-1057.
28. Sullivan E.V., Pfefferbaum A. Diffusion tensor imaging and aging. Neurosci Biobehav Rev 2006, 30:749-761.
29. Toosy A.T., Werring D.J., Orrell R.W., Howard R.S., King M.D., Barker G.J., et al. Diffusion tensor imaging detects corticospinal tract involvement at multiple levels in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2003, 74:1250-1257.
30. Triggs W.J., Menkes D., Onorato J., Yan R.S., Young M.S., Newell K., et al. Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease. Neurology 1999, 53:605-611.
31. Vucic S., Howells J., Trevillion L., Kiernan M.C. Assessment of cortical excitability using threshold tracking techniques. Muscle Nerve 2006, 33:477-486.
32. Vucic S., Kiernan M. Pathophysiology of degeneration in familial amyotrophic lateral sclerosis. Curr Mol Med 2009, 9:255-272.
33. Vucic S., Kiernan M.C. Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease. Brain 2006, 129:2436-2446.
34. Vucic S., Nicholson G.A., Kiernan M.C. Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 2008, 131:1540-1550.
35. Winhammar J.M., Rowe D.B., Henderson R.D., Kiernan M.C. Assessment of disease progression in motor neuron disease. Lancet Neurol 2005, 4:229-238.
36. Zoing M.C., Burke D., Pamphlett R., Kiernan M.C. Riluzole therapy for motor neurone disease: an early Australian experience (1996-2002). J Clin Neurosci 2006, 13:78-83.